Close Menu

NEW YORK – SolGent said on Thursday that it has received the CE mark for its DiaPlexQ Novel Coronavirus (2019-nCoV) Detection assay, as well as authorization from regulatory authorities in Korea and the Philippines.

The company's test qualitatively detects the Orf1a and N genes of the novel coronavirus in sputum, oropharyngeal, and nasopharyngeal specimens from patients with suspected respiratory infection.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.

Dec
03
Sponsored by
Mission Bio

Recent work by many investigators has discovered that over the course of aging, hematopoietic stem cells (HSCs) commonly undergo clonal expansion.